Michel Vounatsos
2018
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $80,663 |
|---|---|
| Non-Equity Incentive Plan | $3,337,880 |
| Salary | $1,276,923 |
| Stock Awards | $11,064,897 |
| Other | $408,283 |
| Total | $16,168,646 |
Vounatsos received $11.1M in stock awards, accounting for 68% of the total pay in 2018.
Vounatsos also received $80.7K of change in pension value and nonqualified deferred compensation earnings, $3.3M in non-equity incentive plan, $1.3M in salary and $408.3K in other compensation.
Rankings
In 2018, Michel Vounatsos' compensation ranked 272nd out of 14,244 executives tracked by ExecPay. In other words, Vounatsos earned more than 98.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 272 out of 14,244 | 98th |
Division Manufacturing | 92 out of 5,758 | 98th |
Major group Chemicals And Allied Products | 30 out of 2,119 | 99th |
Industry group Drugs | 25 out of 1,808 | 99th |
Industry Biological Products, Except Diagnostic Substances | 7 out of 339 | 98th |
Pay ratio
| Michel Vounatsos' Pay | $16,168,646 |
|---|---|
| Median Employee's Pay | $170,521 |
| Pay Ratio | 95to 1 |
In 2018, the annual total compensation of Michel Vounatsos was $16,168,646.
The annual total compensation of the median employee at Biogen was $170,521.
The ratio of Michel Vounatsos' pay to the pay of median employee was therefore 95 to one.
Vounatsos' colleagues
We found four more compensation records of executives who worked with Michel Vounatsos at Biogen in 2018.